Inspection Readiness for Clinical Trials
Quick Answer
We conduct comprehensive readiness assessments, identify gaps in your clinical operations and documentation, and provide hands-on remediation support to ensure your trials pass regulatory inspections. From mock inspections to team training, we prepare you for every aspect of the inspection process.
The Challenge
Regulatory inspections can make or break a clinical trial program. A single inspection finding can delay your NDA submission by months, trigger costly corrective actions, or even result in a clinical hold. Yet many emerging biotech companies don't realize they have inspection readiness gaps until it's too late.
Common issues include incomplete or inconsistent documentation, inadequate training records, poor vendor oversight, and biospecimen handling procedures that don't meet regulatory expectations. These gaps often stem from rapid growth, limited regulatory expertise, or over-reliance on vendors who may not be inspection-ready themselves.
The stakes are especially high for emerging biotech. Unlike large pharma companies with dedicated quality and regulatory teams, smaller organizations often lack the internal resources to conduct thorough self-assessments or prepare effectively for inspections. This is where expert guidance becomes essential.
How It Works
01
Initial Assessment
We conduct a comprehensive review of your clinical operations, quality systems, and documentation practices. This includes evaluating your SOPs, training records, vendor oversight procedures, and biospecimen management systems.
02
Gap Analysis
We identify specific vulnerabilities and prioritize them based on inspection risk and regulatory impact. You receive a detailed gap analysis report with clear findings and risk ratings.
03
Remediation Planning
We develop a prioritized remediation roadmap with specific action items, timelines, and resource requirements. This plan is tailored to your upcoming milestones and inspection timeline.
04
Implementation Support
We provide hands-on support to implement corrective actions, update documentation, train your team, and strengthen vendor oversight. This includes developing new SOPs, conducting training sessions, and improving quality systems.
What's Included
Comprehensive inspection readiness assessment
Prioritized remediation roadmap
Training program development and delivery
Mock inspection exercises
Document retrieval system optimization
Regulatory intelligence updates
Detailed gap analysis report with risk rating
SOP review and development support
Vendor inspection readiness assessment
Inspection question preparation
Post-inspection supprot and CAPA development
Ongoing readiness maintenance guidance
Who It's For
This service is designed for small biotech companies preparing for their first regulatory inspection, organizations that have received inspection findings in the past, and companies expanding into new therapeutic areas or geographies.
It's particularly valuable for sponsors approaching key regulatory milestones like BLA submission, who need to ensure their clinical operations and vendor partners are inspection-ready. Whether you're conducting your first Phase 1 trial or preparing for a pre-approval inspection, we provide the expertise and hands-on support to help you succeed.
Frequently Asked Questions
Ideally, inspection readiness should be built into your operations from day one. However, if you're facing an imminent inspection, we recommend starting preparation at least 3-6 months in advance to allow time for gap remediation and team training.
We prepare you for FDA pre-approval inspections, routine surveillance inspections, for-cause inspections, and international regulatory inspections (EMA, PMDA, etc.). Our approach covers both clinical and bioanalytical inspection scenarios.
We provide a prioritized remediation roadmap with clear timelines and resource requirements. We can also provide hands-on support to implement corrective actions and verify their effectiveness before the actual inspection.
Absolutely. We work with your CROs, laboratories, and other vendors to ensure they meet inspection readiness standards. This includes reviewing their quality systems, conducting mock inspections, and providing remediation support.